Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Type 2 Diabetes – Access & Reimbursement – Access & Reimbursement – Type 2 Diabetes (US)
The sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists are frequently prescribed for type 2 diabetes (T2D). These classes, along with glucose-…
Atopic Dermatitis / Atopic Eczema – Geographic Focus: China – Atopic Dermatitis/Atopic Eczema – China In-Depth (China )
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by pruritus and eczema that significantly affects patients’ quality of life. It is traditionally treated with…
Rheumatoid Arthritis – Geographic Focus: China – Rheumatoid Arthritis – China In-Depth (China)
Rheumatoid arthritis (RA) is a chronic and progressive autoimmune disease that primarily affects the joints. China has the highest number of RA patients in the world, and disease management is…
Chronic Obstructive Pulmonary Disease | Disease Landscape & Forecast | G7 | 2023
The chronic obstructive pulmonary disease (COPD) therapy market continues to gradually shift away from LABA/ICS FDCs toward LABA/LAMA FDCs and LABA/LAMA/ICS FDCs, but current and emerging generics…
